Clinical Trials Browser

INDUSTRY × Interventional × IMC-001 × Clear all

NCT04414163 2026-04-24

A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type

Phase 2 Active not recruiting

23 enrolled

Lymphoid

Lymphoma, Extranodal NK-T-Cell

NCT06365840 2026-04-17

TMB-H

Phase 2 Recruiting

30 enrolled

Other solid neoplasm

TMB-H

NCT03999658 2023-05-01

A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies

Phase 2 Withdrawn

GastrointestinalLymphoid

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Cholangiocarcinoma, Lymphoma, Extranodal NK-T-Cell

NCT03644056 2020-05-28

Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid Tumors

Phase 1 Completed

15 enrolled

Tumor-Agnostic

Neoplasm Metastasis